Genetec Technology Berhad Balance Sheet Health
Financial Health criteria checks 6/6
Genetec Technology Berhad has a total shareholder equity of MYR496.7M and total debt of MYR14.8M, which brings its debt-to-equity ratio to 3%. Its total assets and total liabilities are MYR567.7M and MYR71.0M respectively. Genetec Technology Berhad's EBIT is MYR72.7M making its interest coverage ratio 430.5. It has cash and short-term investments of MYR164.4M.
Key information
3.0%
Debt to equity ratio
RM 14.80m
Debt
| Interest coverage ratio | 430.5x |
| Cash | RM 164.40m |
| Equity | RM 496.73m |
| Total liabilities | RM 70.98m |
| Total assets | RM 567.71m |
Recent financial health updates
Is Genetec Technology Berhad (KLSE:GENETEC) A Risky Investment?
Aug 06
Does Genetec Technology Berhad (KLSE:GENETEC) Have A Healthy Balance Sheet?
Nov 17Genetec Technology Berhad (KLSE:GENETEC) Has A Pretty Healthy Balance Sheet
Jul 21Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly
Feb 24Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly
Nov 04Is Genetec Technology Berhad (KLSE:GENETEC) Using Debt In A Risky Way?
Jun 11Recent updates
Genetec Technology Berhad (KLSE:GENETEC) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Oct 23Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher
Sep 22Genetec Technology Berhad (KLSE:GENETEC) Analysts Are More Bearish Than They Used To Be
Aug 27Not Many Are Piling Into Genetec Technology Berhad (KLSE:GENETEC) Stock Yet As It Plummets 27%
Aug 19Is Genetec Technology Berhad (KLSE:GENETEC) A Risky Investment?
Aug 06Genetec Technology Berhad's (KLSE:GENETEC) P/E Still Appears To Be Reasonable
Feb 26Slowing Rates Of Return At Genetec Technology Berhad (KLSE:GENETEC) Leave Little Room For Excitement
Jan 15Genetec Technology Berhad's (KLSE:GENETEC) CEO Will Probably Have Their Compensation Approved By Shareholders
Sep 22Does Genetec Technology Berhad (KLSE:GENETEC) Deserve A Spot On Your Watchlist?
Feb 08Genetec Technology Berhad (KLSE:GENETEC) Is Investing Its Capital With Increasing Efficiency
Dec 28Does Genetec Technology Berhad (KLSE:GENETEC) Have A Healthy Balance Sheet?
Nov 17Investors Shouldn't Overlook Genetec Technology Berhad's (KLSE:GENETEC) Impressive Returns On Capital
Aug 16Genetec Technology Berhad (KLSE:GENETEC) Has A Pretty Healthy Balance Sheet
Jul 21Genetec Technology Berhad (KLSE:GENETEC) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 30Genetec Technology Berhad's (KLSE:GENETEC) Intrinsic Value Is Potentially 93% Above Its Share Price
Apr 28Why We Like The Returns At Genetec Technology Berhad (KLSE:GENETEC)
Mar 23Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly
Feb 24Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly
Nov 04The CEO Of Genetec Technology Berhad (KLSE:GENETEC) Might See A Pay Rise On The Horizon
Sep 08Genetec Technology Berhad's (KLSE:GENETEC) Robust Earnings Are Not All Good News For Shareholders
Aug 05Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher
Jul 30Is Genetec Technology Berhad (KLSE:GENETEC) Using Debt In A Risky Way?
Jun 11How Well Is Genetec Technology Berhad (KLSE:GENETEC) Allocating Its Capital?
Feb 10Why Genetec Technology Berhad's (KLSE:GENETEC) CEO Pay Matters
Jan 14Here's Why Genetec Technology Berhad (KLSE:GENETEC) Can Manage Its Debt Responsibly
Dec 24
Genetec Technology Berhad's (KLSE:GENETEC) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?
Dec 03Financial Position Analysis
Short Term Liabilities: GENETEC's short term assets (MYR422.3M) exceed its short term liabilities (MYR62.1M).
Long Term Liabilities: GENETEC's short term assets (MYR422.3M) exceed its long term liabilities (MYR8.8M).
Debt to Equity History and Analysis
Debt Level: GENETEC has more cash than its total debt.
Reducing Debt: GENETEC's debt to equity ratio has reduced from 19.1% to 3% over the past 5 years.
Debt Coverage: GENETEC's debt is well covered by operating cash flow (228.3%).
Interest Coverage: GENETEC's interest payments on its debt are well covered by EBIT (430.5x coverage).